0001209191-20-020167.txt : 20200319
0001209191-20-020167.hdr.sgml : 20200319
20200319080919
ACCESSION NUMBER: 0001209191-20-020167
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200317
FILED AS OF DATE: 20200319
DATE AS OF CHANGE: 20200319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Griffin Deborah A
CENTRAL INDEX KEY: 0001719115
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16174
FILM NUMBER: 20726448
MAIL ADDRESS:
STREET 1: 5 BASEL STREET, P.O. BOX 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 4951033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD
CENTRAL INDEX KEY: 0000818686
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 BAZEL ST
STREET 2: P O B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
BUSINESS PHONE: 9729267267
MAIL ADDRESS:
STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
STREET 2: 5 BAZEL ST PO B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-17
0
0000818686
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA
0001719115
Griffin Deborah A
C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.
5 BASEL STREET
PETACH TIKVA
L3
4951033
ISRAEL
0
1
0
0
Chief Accounting Officer
Ordinary Shares
2020-03-17
4
M
0
944
A
944
D
Ordinary Shares
2020-03-17
4
S
0
944
7.1635
D
0
D
Restricted Share Units
2020-03-17
4
M
0
944
0.00
D
Ordinary Shares
944
0
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.1600 to $7.1850, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
Restricted share units were granted on March 17, 2016, with 943 vesting on each of March 17, 2018 and March 17, 2019 and 944 vesting on March 17, 2020.
/s/ Dov Bergwerk as attorney-in-fact for Deborah A. Griffin
2020-03-19